Novartis · 1 day ago
Therapeutic Area Strategy Head, CRM
Novartis is a global healthcare company that aims to improve and extend people's lives. They are seeking a Therapeutic Area Strategy Head to lead a team in creating and updating an enterprise portfolio strategy for the cardio-renal-metabolic therapeutic area, working closely with senior leaders and driving sustainable growth through strategic insights and analysis.
BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
Responsibilities
Builds and maintains in-depth knowledge of the TA (early pipeline to commercial); including disease models; responsible for ongoing assessment of peer companies with heavy exposure in the TA
Educates, updates and provides external views to all internal stakeholders. Provides insight within key portfolio governance processes (diligence and external landscape mapping with BD&L and M&A)
Supports identification of growth accretive opportunities, indications, disease spaces and rejection of low value opportunities/projects
Supports Group Investor Relations and the CEO Office with dissemination of key strategic insights
Ongoing collection and synthesis of scientific and commercial insights for the TA
Leads the process of creating, maintaining and updating enterprise-wide TA portfolio strategy, including disease area and molecule selection to drive mid- and long-term growth in collaboration with RDC
Identifies potential pipeline gaps, makes recommendations to address
Works closely with key stakeholders in the Therapeutic Area Leadership (TAL) team to facilitate portfolio decision making, prioritization and trade-offs
Oversees assessments of programs fit to current portfolio strategy and facilitates central review for assets inside and outside current priorities (e.g., at Innovation Management Board (IMB))
Provides consolidated commercial and development inputs to support business cases for internal and external assets and programs
Provides outside-in independent view of internal assumptions around core pipeline
Leads the development of assessment of external opportunities (e.g., forecast assumptions, business cases)
Coaches, attracts, develops, and retains top talents; partners with P&O leadership to develop people strategy (e.g. organization development, performance, career development)
Plans, allocates, and manages TA strategy financial budget by anticipating expenditures, accurately forecasting resource needs/costs and properly accounting for expenses to meet requirements and achieve fiscal responsibility
Qualification
Required
Advanced degree or equivalent experience in life science/healthcare required, Cardiologist training highly desirable
Demonstrated cross‑functional global leadership experience is essential
Minimum 10 years of pharmaceutical/biotech experience gained in banking, consulting, or biopharma, with exposure to drug development and ideally commercialization required. Proven ability to operate effectively in a highly matrixed, fast paced environment
Ability to comfortably engage with the C-suite and mid-career associates to influence and challenge with excellent interpersonal and leadership skills
Strong financial and business acumen with strong understanding of biopharma landscape; companies, assets and early technologies
Strong strategic vision, superior leadership, excellent communication, consensus building, and well-developed influencing and negotiation skills
Excellent conflict resolution skills to facilitate agreement and buy-in at the senior-most levels
Experience leading and managing a team with a variety of insights from science to commercial and proven coaching and mentoring experience
Preferred
Candidates with significant senior leadership experience — including Biotech CEOs and executives from investment banking or other Wall Street institutions are strongly preferred
Benefits
Health, life and disability benefits
A 401(k) with company contribution and match
A variety of other benefits
Generous time off package including vacation, personal days, holidays and other leaves
Company
Novartis
Novartis is a pharmaceutical company that researches and develops medicines for serious diseases to improve and extend people's lives.
H1B Sponsorship
Novartis has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (14)
2024 (27)
2023 (23)
2022 (27)
2021 (31)
2020 (25)
Funding
Current Stage
Public CompanyTotal Funding
$2.49BKey Investors
Bill & Melinda Gates Foundation
2024-06-19Post Ipo Debt· $2.49B
2018-02-14Grant· $6.5M
2000-05-19IPO
Leadership Team
Recent News
2026-01-23
Company data provided by crunchbase